Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies

被引：1
|
作者：
Upadhayaya, Ram S. [1 ]
Kethiri, Raghava Reddy [1 ]
Vellanki, Avanish [2 ]
Lightfoot, Jeff [3 ]
Local, Andrea [4 ]
Rice, William G. [4 ]
机构：
[1] Laxai Avanti Life Sci, Hyderabad, Andhra Pradesh, India
[2] Aptose Biosci Inc, Redwood City, CA USA
[3] Aptose Biosci Inc, Mississauga, ON, Canada
[4] Aptose Biosci Inc, San Diego, CA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5212.5212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5212
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
    Ember, Stuart W. J.
    Zhu, Jin-Yi
    Olesen, Sanne H.
    Martin, Mathew P.
    Becker, Andreas
    Berndt, Norbert
    Georg, Gunda I.
    Schoenbrunn, Ernst
    ACS CHEMICAL BIOLOGY, 2014, 9 (05) : 1160 - 1171
  • [32] Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors
    Liu, Shuai
    Yosief, Hailemichael O.
    Dai, Lingling
    Huang, He
    Dhawan, Gagan
    Zhang, Xiaofeng
    Muthengi, Alex M.
    Roberts, Austin
    Buckley, Dennis L.
    Perry, Jennifer A.
    Wu, Lei
    Bradner, James E.
    Qi, Jun
    Zhang, Wei
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) : 7785 - 7795
  • [33] Discovery of indol-6-yl-pyrrolo[2,3-c]pyridin-7-one derivatives as bromodomain-containing protein 4 (BRD4) inhibitors for the treatment of kidney fibrosis
    Tao, Sibei
    Tao, Shaohua
    Guo, Fan
    Zhang, Lidan
    Zhao, Lifeng
    Fu, Ping
    Ma, Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
  • [34] Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling
    Brasier, Allan R.
    Zhou, Jia
    DRUG DISCOVERY TODAY, 2020, 25 (01) : 126 - 132
  • [35] Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3
    Li, Yingxiu
    Ye, Tianyu
    Xu, Le
    Dong, Yuhong
    Luo, Yong
    Wang, Chu
    Han, Yufei
    Chen, Ke
    Qin, Mingze
    Liu, Yajing
    Zhao, Yanfang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 181
  • [36] Discovery and optimization of 2-aminopyridine derivatives as novel and selective JAK2 inhibitors
    Ma, Xiangyu
    Diao, Yanyan
    Ge, Huan
    Xu, Fangling
    Zhu, Lili
    Zhao, Zhenjiang
    Li, Honglin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (08)
  • [37] Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach
    Shanmugam, Vaishnavi
    Muthukrishnan, Soundararajn
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 14524 - 14539
  • [38] Discovery of CYT387: A potent and selective dual inhibitor of JAK1 and JAK2
    Burns, Christopher J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [39] Discovery of selective and potent BRD4 protein degraders using Plexium's DELPhe platform.
    Parker, Gregory S.
    Toth, Julia A.
    Leriche, Geoffray
    Bailey, Simon
    Chng, Kenneth
    Fish, Sara
    Jamborcic, Aleks
    Daniele, Elizabeth
    Green, Erika
    Hocker, Michael
    Kallel, Adam
    Thompson, Peggy A.
    Brown, Steven D.
    Vijayan, Kandaswamy
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein
    Brannon, AR
    Maresca, JA
    Boeke, JD
    Basrai, MA
    McBride, AA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) : 2998 - 3003
12345